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Global Health, Aid Effectiveness and 
the Changing Role of the WHO
Wolfgang Hein and Ilona Kickbusch
The fear of pandemics, the significance of health in the fight against poverty, and a pro-
liferation of new actors have increasingly directed international attention towards glo-
bal health. In this context, the financial resources available for global health as well as 
the flexibility in problem solving have increased significantly, but at the cost of a prolif-
eration of public and private actors which tends to inhibit the effective use of these re-
sources. The Paris Declaration on Aid Effectiveness has been broadly embraced in glo-
bal health, and there has been a reappraisal of the coordinating role of the World Health 
Organization (WHO). 
Analysis
Since the 1990s the growing number of actors involved has considerably changed the 
field of global health governance (GHG). Partnerships between states, international 
governmental organizations (IGOs) such as the WHO, the pharmaceutical industry, and 
also civil society organizations have helped overcome conflicts between the profit-driv-
en production of medicines and the health needs of poor countries. However, they have 
also led to a vast entanglement of responsibilities, with the WHO losing its profile as 
the central authority on global health. In recent years, however, the impacts of the Paris 
Declaration on GHG and a number of other processes have again strengthened the po-
sition of the WHO:
Important efforts have been undertaken to improve effectiveness in global health.
Initiatives at the country level have strengthened support for national health systems.
At the WHO two binding international agreements have been concluded and are 
now administered in Geneva: the Framework Convention on Tobacco Control and 
the (new) International Health Regulations. Increasing the participation of non-state 
actors through organizational reforms could further strengthen the WHO’s role.
In 2008 the WHA passed the Global Strategy and Plan of Action on Public Health, Inno-
vation and Intellectual Property Rights. The 2010 WHA discussed proposals to finance 
this strategy, but adjourned the decision to 2011.
On May 10, 2010, the Council of the European Union adopted the far-reaching Con-
clusions on the EU role in Global Health, supporting “increased leadership of the WHO 
at global, regional and country level” and improved access to medicines and health 
services in developing countries.
Keywords:  global health governance, health partnerships and systems, aid effectiveness, 
WHO reform
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1.	 The	Concept	of	Global	Health	Governance
Since the 1990s a proliferation of actors has been 
observable in the health sector, this has affected 
GHG even more than similar developments in 
other fields of global governance. In addition to 
a growing number of civil society organizations 
(CSOs), many new types of actors and global ini-
tiatives (for example, foundations, public-private 
partnerships, or the Global Fund to Fight AIDS, 
Tuberculosis and Malaria (GFATM)) are interact-
ing with national governments and IGOs. The 
term global health governance was introduced in-
to the academic discourse around the year 2000. 
GHG can be understood as a mechanism for col-
lective problem-solving, that is, health improve-
ments through the interplay of different insti-
tutional forms and actors at different levels (see 
GIGA Focus Global No. 7/2006). Some GHG in-
stitutions were explicitly created to sideline IGOs 
such as the WHO or the World Bank, which were 
considered too bureaucratic and not sufficiently 
results oriented.
GHG implies a substantive concern with issues 
that affect populations worldwide, either direct-
ly (for example, the global spread of diseases such 
as HIV/AIDS and the highly feared new influenza 
pandemic) or indirectly (extreme inequalities in 
medical care, unhealthy consumption patterns). 
The emergence of new actors in global health has 
not only added expertise and financial resources 
to the field of international health (see Figure 1) 
but has also contributed to a higher degree of flex-
ibility in dealing with global health problems.
2.	 The	Importance	of	Health	Partnerships
Global health partnerships (GHPs, frequent-
ly used interchangeably with global health initia-
tives (GHIs)) have contributed significantly to 
fundamental changes in the architecture of inter-
national health policies over the last 20 years. 
Through the integration of a number of different 
actors—government health departments, interna-
tional multi- and bilateral organizations, pharma-
ceutical enterprises, private foundations, and civil 
society organizations—in different combinations 
as required by the specific tasks and the social and 
political environments, flexible forms of cooper-
ation have become possible. These partnerships 
combine the specific needs identified by govern-
ments, IGOs, or CSOs with the scientific and tech-
nological capacities of private corporations and 
the financial resources of donor countries, public 
funds, or private foundations.
Figure	1:		 Development	Assistance	for	
Health	from	1990	to	2007	by	
Channel	of	Assistance
Note:  The bar graph represents the contributions of 
specific (groups of) donors in the same sequence 
as in the legend. (BMGF: Bill and Melinda Gates 
Foundation; GAVI: Global Alliance on Vaccines 
and Immunization)
Source:  Ravishankar et al. 2009: 2115.
During recent years, GHPs have made important 
contributions to research on neglected diseases,1 
to financing for health activities in specific fields 
such as HIV/AIDS and immunization, and to im-
proving access to medicines in poor regions. How-
ever, they also entail a number of problems:
(1) The tendency in global health to focus pri-
marily on controlling and treating specific diseas-
es (in developing countries, the “diseases of the 
poor”) has been reinforced by GHPs. Their activ-
ities are linked to a predominantly vertical orien-
tation, that is, a chain of activities focusing on spe-
cific diseases and including the identification of 
pathogens, research and development on medi-
cines and means of treatment, the distribution of 
medicines, the securing of access to financing and 
technical infrastructure, and the medical infra-
1 These are diseases on which e�penditures on R��� had been          
small due to a lack of private incentives for a lack of purchas-
ing power of affected persons or countries.
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structure for treatment. Horizontal activities such 
as improving national health systems and devel-
oping primary health care (PHC) systems have 
been relatively neglected.
(2) There has been a growing critique concern-
ing a lack of legitimacy and accountability on the 
part of most of the new non-state actors in GHG. 
Large CSOs, GHPs, and financially strong founda-
tions (such as the Bill and Melinda Gates Founda-
tion) are having an important impact on the ori-
entation of global health without being accounta-
ble to the people affected by their activities. While 
IGOs may also suffer from legitimacy problems, 
they are clearly accountable to governing bodies 
in which sovereign states are represented.
Figure	2:		 Actors	in	Global	Health
Note: Abbreviations (excluding the well-known UN 
organizations): GHIs: Global Health Initiatives; 
TNCs: Transnational Corporations; GAVI: Glo-
bal Alliance for Vaccines and Immunization; 
UNFPA: United Nations Population Fund. 
Source:  W. Hein.
(3) International cooperation is becoming more 
complex. Poor countries are receiving aid from a 
growing number of different organizations. This 
has made it difficult for national governments to 
pursue consistent national strategies to develop 
their health systems.
3.	 The	Paris	Declaration	and	Its	Impact	on	the	
Health	Sector
After the adoption of the Millennium Develop-
ment Goals (MDGs) in 2000, the OECD and the 
World Bank organized a global discourse on the 
effectiveness of development cooperation. The 
growing number of international and transnation-
al actors tended to reduce the capacity of develop-
ing-country governments to pursue effective na-
tional strategies. Particularly in the poorest coun-
tries, it appeared difficult to achieve the MDGs 
without a thoroughgoing reform of international 
cooperation. 
The International Conference on Financing for 
Development in Monterrey, Mexico (2002) paved 
the way for a negotiation process which led to 
the Paris Declaration on Aid Effectiveness (2005). 
The declaration articulates five target areas of im-
provement for aid effectiveness: ownership, har-
monization, alignment, results, and mutual ac-
countability. Donor countries will coordinate and 
harmonize their aid in order to effectively support 
their partners’ national development strategies, 
which will in turn basically follow international-
ly agreed-upon concepts of good governance. The 
results of cooperation are jointly evaluated. 
By explicitly addressing the problem of the 
multiplicity of donors in relation to the goal of 
“delivering effective aid,” the Paris Declaration al-
so reacts to the central problems in GHG. For ex-
ample, during the preparation process for the Ac-
cra High Level Forum on Aid Effectiveness (a 2008 
follow-up meeting to the Paris conference in Ac-
cra, Ghana), the WHO, the World Bank and OECD 
proposed using health as “‘tracer sector’ for track-
ing progress on the Paris Declaration.” They point-
ed out that “aid effectiveness is particularly chal-
lenging in health. As with other sectors, difficul-
ties are the result of inefficiencies in the global aid 
architecture and of poor country policies; howev-
er, problems in health are exacerbated by the in-
herent complexities of the sector itself” (OECD/
DAC 2007: 5).
Global health is affected by the Paris-Accra 
Agenda in all areas which demand country-lev-
el coordination. This also includes the national 
and local coordination of disease-oriented pro-
grams. UNAIDS has promoted several coordina-
tion activities, of which the concept of the “Three 
Ones” (2004) is the most important. It aims to es-
tablish one agreed-upon HIV/AIDS action frame-
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work that provides the basis for coordinating the 
work of all partners, one national AI��S coordinat-
ing authority, and one agreed-upon country-lev-
el monitoring and evaluation system (WB/WHO 
2006: 15). Related to this, the Country Harmoni-
zation and Alignment Tool (CHAT), developed by 
UNAIDS and the World Bank, was presented in 
2007. 
4.	 Health	Systems	and	Primary	Health	Care
Health has an important place among the MDGs. 
The health-related MDGs (focused on infectious 
diseases, maternal health, child mortality, and ac-
cess to medicines) correspond to the vertical ap-
proaches to global health dominant in the 1990s. 
This vertical approach implied a neglect not on-
ly of coordinated support for national health sys-
tems but in particular of approaches geared to-
ward the support of marginalized population 
groups. The slow progress on many health indica-
tors that resulted, in spite of the rapid growth in 
resources invested, led to the refocusing of health 
aid on health systems, and particularly PHC, in 
order to improve the chances of meeting the MDG 
targets.
The High-level Forum (HLF) on the Health 
MDGs (World Bank & WHO 2006) held three meet-
ings in 2004 and 2005. “Scaling up aid for health” 
was the HLF’s main goal and implied better co-
ordination between GHPs, the improvement of 
health funding, and concrete strategies to support 
the development of health systems in poor coun-
tries. “Best practice principles for GHPs” demand-
ed adherence to the Paris ��eclaration principles 
and the establishment of an issue-oriented annual 
forum to be supplemented by more informal liai-
son and information-sharing between the largest 
GHPs. The nonalignment of funding with govern-
ment priorities (50 percent is earmarked for spe-
cific diseases or programs), the lack of long-term 
support, and the volatility of funding were criti-
cized. 
The Scaling Up for Better Health (IHP+) Initi-
ative was jointly established by the most impor-
tant health funders. The IHP+ process is led by 
the so-called Scaling-up Reference Group (SuRG), 
which brings together the eight most important 
agencies/initiatives in global health—WHO, the 
World Bank, GAVI, UNICEF, UNFPA, UNAIDS, 
the GFATM, and the Bill and Melinda Gates Foun-
dation—which have as a group gained impor-
tance beyond IHP+ under the name Health 8. The 
group is tasked with providing centralized over-
sight and coordination of all the initiatives in 
which the eight agencies participate, for instance, 
the International Health Partnership, the Cat-
alytic Initiative to Save a Million Lives, the Glo-
bal Campaign for the Health MDGs, and Provid-
ing for Health. The focus of all IHP+ initiatives is 
on achieving health-related MDG outcomes by in-
creasing aid effectiveness; improving policy, strat-
egy and health systems performance; and mobi-
lizing all actors, including non-state actors. Ac-
tions are country focused and country led.
The concept of primary health care was 
launched by the WHO at the Alma Ata confer-
ence in 1978 as a guideline for a comprehensive 
health policy. It was a core element of the strate-
gy to achieve “Health for All” and has to be seen 
in the conte�ts of social, economic, and cultural 
human rights and of the call for a new interna-
tional economic order. The importance of commu-
nity participation and nongovernmental organ-
izations (NGOs) for PHC was particularly high-
lighted in Africa. In the 1980s the implementation 
of the PHC concept was hindered by a variety of 
factors, among them the politics of the Washing-
ton Consensus, a shift towards selective PHC and 
the control of infectious diseases, and the lack of 
a long-term political and financial commitment to 
comprehensive PHC. Within the discourses on the 
MDGs and aid effectiveness in recent years PHC 
has received renewed attention.
What is the role of non-state actors in promot-
ing health care in poor countries? In a recent meet-
ing of experts on the role of GHPs in low-income 
countries (Berlin, September 21, 2009), the contri-
bution of the private sector to health systems in 
poor countries generated acute controversy. Civ-
il society organizations like Oxfam criticized the 
“myths about private health care in poor coun-
tries” as “blind optimism.” They view the sub-
stantial proportion of private actors in total health 
care in many poor countries basically as a conse-
quence of state failure.
According to data on India, although the pri-
vate sector provides 82 percent of outpatient care 
in the country, 50 percent of women actually have 
no medical assistance whatsoever during child-
birth. Seventy-three percent of private health-
care providers in Malawi are just shops which sell 
some medicines, while 15 percent are traditional 
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healers. Upgrading public capacity is more effec-
tive than private sector investments. 
Other contributors to the Berlin meeting, how-
ever, suggested that—in the context of a govern-
ment-led health program—it may not be so im-
portant whether a hospital is run by a private or 
public operator; however, where it might be diffi-
cult to find private investments, for example, for 
educating more health personnel, public resourc-
es. Quality is closely related to the appropriate 
regulation of the sector, something which is gen-
erally accepted as the task of the state. In general, 
however, it has been agreed that private sector in-
volvement in partnerships should go beyond the 
traditional involvement in offering health services 
and participation in product development and ac-
cess-oriented partnerships. It should focus more 
on the broader issues in the fields of health financ-
ing, such as insurance systems and the instruction 
of more health-care personnel.
5.	 The	Role	of	the	WHO
Recent developments document the fact that there 
is broad agreement on the urgent need for more 
coordination in GHG. Reactions to the Paris Dec-
laration relate to development cooperation, which 
is only one aspect of global health. There is a need 
for global health diplomacy in the sense of an au-
thoritative reconciliation of interests and concepts 
through negotiations and compromises. Is there 
now a chance to overcome the critical positions of 
many industrialized countries, as well as of non-
state actors, which have weakened the WHO’s role 
in global health since the 1990s?
The WHO was created in 1948 to “act as the 
directing and co-ordinating authority on interna-
tional health work” (Constitution of the WHO, 
Art. 2a). It was entrusted with the task of “estab-
lishing and maintaining effective collaboration 
with the United Nations, specialized agencies, 
governmental health administrations, profession-
al groups and such other organizations as may be 
deemed appropriate” (Constitution of the WHO, 
Art. 2b). The WHO was established as an IGO with 
three organs: the WHA, the Executive Board and 
the Secretariat. The Executive Board was original-
ly conceived of as a regionally balanced body of 
experts technically qualified in the field of health 
(Art. 24). Its members were to “exercise power del-
egated to them by the Conference on behalf of the 
whole Conference, and not as representatives of 
their respective governments” (Kickbusch, Hein, 
and Silberschmidt 2010). This was changed in the 
late 1990s so that the members now also repre-
sent their countries. Aside from the addressing of 
technical matters, WHO negotiations have most-
ly involved coalition- and bloc-building process-
es among nations as well as periodic attempts by 
powerful states to curtail the organization’s auton-
omy—at times bringing the WHO close to paral-
ysis.
These problems have certainly played a role 
in stimulating new actors to move into the health 
arena and to search for new institutional arrange-
ments. But to some e�tent, nation-states them-
selves have weakened their own organization, 
particularly through the cap on assessed contri-
butions since the so-called United Nations Re-
form Act (Helms-Biden Act), a 1999 US law that 
set a number of conditions for the reform of the 
UN system before the US would release its total 
amount of arrears in payment to the UN. This in-
troduced the principle of zero nominal growth in-
to the WHO budget process and forced the organ-
ization to be dependent on extra-budgetary re-
sources. This becomes a problem when the WHO 
is forced to compete for funding with other bod-
ies, NGOs, and even countries: the “steady shift to 
a competitive model of funding runs the risks (sic) 
of undermining their crucial role as trusted neu-
tral brokers between the scientific and the tech-
nical communities on the one hand, and govern-
ments of developing countries on the other” (Ravi-
shankar et al. 2009).
In spite of these problems, the WHO has par-
tially regained its central position in recent years. 
It has increasingly assumed a more active role in 
global health diplomacy, particularly through the 
successful negotiation of two important interna-
tional agreements, the Framework Convention on 
Tobacco Control (FCTC) and the new Internation-
al Health Regulations, which played an important 
role in the coordination of the control of SARS, the 
avian flu, and the “swine flu” (Pandemic Influen-
za, H1N1; see: GIGA Focus Global 3/2009).
Furthermore, the WHO has used high-level ex-
pert commissions to organize focused discours-
es on important global health issues. These most-
ly consist of members representing stakehold-
ers from quite diverse political and cultural back-
grounds and are established for a limited peri-
od of time to produce substantial reports on top-
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ics of far-reaching importance, including influen-
tial policy recommendations (similarly to the so-
called Brundtland Commission and the Commis-
sion on Global Governance).
Three such commissions have been initiat-
ed and managed by the WHO since the turn of 
the century: the Commission on Macroeconomics 
and Health (CMH), the Commission on the Social 
Determinants of Health (CSD), and the Commis-
sion on Intellectual Property Rights, Innovation 
and Public Health (CIPIH). These commissions 
have turned out to be important policy-making 
tools that help coordinate the multiplicity of ac-
tors in GHG by allowing an open discourse be-
tween stakeholders with conflicting interests and 
produce a meaningful focus for the strategic de-
bates and decision making of participating organ-
izations. They can also refer problems which need 
decisions by state authorities to the WHA.
This new form of activity on the part of the 
WHO has proven to be particularly important in 
the field of innovation and public health. Follow-
ing the publication of the CIPIH’s final report in 
2006 (CIPIH/WHO 2006), a consensus began to 
emerge on the need for changes to the global sys-
tem of innovation for medicines and for health re-
search more generally. This led to the establish-
ment of the Intergovernmental Working Group on 
Public Health, Innovation and Intellectual Prop-
erty (IGWG) under the auspices of the WHO. The 
IGWG, open to all interested member states and 
including civil society actors, was mandated to 
draw up a global strategy and plan of action. Its 
aim was to provide a medium-term framework 
to secure an enhanced and sustainable basis for 
needs-driven, research and development on essen-
tial medicines relevant to diseases that dispropor-
tionately affect developing countries. This Global 
Strategy and parts of the Plan of Action were adopt-
ed in a resolution passed at the WHA in May 2008 
(WHA 61.21). The WHA 2010 discussed concepts 
for financing the Plan of Action, which is quite a 
difficult prospect considering the Taskforce on In-
novative International Financing for Health Sys-
tems’ estimate that by 2015 USD7.4 billion will be 
necessary annually for funding health research 
and development. Finally, due to concerns raised 
by some countries about the task force’s approach, 
a new consultative working group was appoint-
ed and the decision adjourned to the next WHA 
in 2012. Whatever the final result, this process in-
dicates that the WHO is now in a position to lead 
negations on large-scale funding, whereas the US 
and other industrial countries insisted on estab-
lishing the GFATM outside of the UN system. 
In a recent statement, the Council of the Euro-
pean Union (2010) called for support for the “in-
creased leadership of the WHO at [the] global, 
regional and country level” (conclusion 12). The 
council also requested “Member States to gradu-
ally move away from earmarked WHO funding 
towards funding its general budget” (conclusion 
12) and, concerning intellectual property rights, 
to “support third countries, in particular LDCs, in 
the effective implementation of flexibilities for the 
protection of public health provided for in TRIPs 
agreements, in order to promote access to med-
icines for all” (conclusion 16a). Furthermore, the 
council called “on the EU and its Member States 
to promote effective and fair financing of research 
that benefits the health of all” and demanded ex-
ploratory models in relation to the WHO’s Global 
Strategy and Plan of Action (conclusion 18).
6.		Adapting	the	WHO	to	GHG	through	
Institutional	Reforms
As the world’s primary health authority, the WHO 
has a responsibility to safeguard public interests 
in conflicts on global health and is the only legiti-
mate entity for setting a central agenda for govern-
ing global health. None of the coordination mech-
anisms mentioned thus far has the same obliga-
tion to serve the public interest, to demonstrate 
fairness in decision making, and to act in a com-
pletely transparent matter.
Lawrence O. Gostin, professor of international 
law, has proposed that the WHO take full advan-
tage of its treaty-making capabilities and establish 
a Framework Convention on Global Health that 
bindsall major stakeholders (states as well as non-
state actors) to the aims of building capacity, set-
ting priorities, coordinating activities, and mon-
itoring progress. He feels that global health ef-
forts ought to be shifted to focus on basic survival 
needs, something which would require the coor-
dinated political and financial commitment of all 
relevant actors (Gostin 2007). 
A second proposal focuses on the importance 
of the WHA (Kickbusch, Hein, and Silberschmidt 
2010). For a productive coordination process lead-
ing to the “harmonization of conflicting strategies” 
and reaching beyond a clash of fixed positions, 
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the WHO should be in a position to make much 
better use of the processes of nodal governance, 
which allow continuous interaction in the respec-
tive fields between basically all actors concerned. 
The WHA ensures the interface between the dele-
gates of its members (nation-states) as well as the 
interface of these delegates with the representa-
tives of many other global health actors. Quite in-
dependent from what is being discussed on the 
assembly’s formal agenda, the new “polylateral 
diplomacy” (Wiseman 1999, note 10) is conducted 
throughout the WHA: Formal and informal meet-
ings take place, agreements are reached, deals are 
struck, NGOs exert influence, the private sector 
lobbies, receptions are organized. In short, key 
global health players participate in the assembly 
even if they are not part of the formal meetings. 
The Constitution of the World Health Organi-
zation has not yet been fully leveraged as a vehi-
cle for global health governance. As the only le-
gitimate supranational authority on health issues, 
the WHO is the appropriate vessel for housing a 
centralized coordination mechanism that brings 
all prominent global health actors to the table for 
harmonized agenda setting and decision making. 
As such, it has been recommended that a Com-
mittee C of the WHA be established, which—in ad-
dition to member-state representatives—involves 
the active participation of international agencies, 
philanthropic organizations, multinational health 
initiatives, and representatives from major civil 
society groups, particularly those who legitimate-
ly represent the most vulnerable populations. The 
work of such a group would complement the cur-
rent Committee A’s program focus and the budget 
and managerial responsibilities of Committee B. 
The proposed Committee C would debate ma-
jor health initiatives and provide an opportuni-
ty for the primary players involved in health to 
present their plans and achievements to, and dis-
cuss collective concerns with, the WHA’s member-
state representatives. The committee would then 
pass resolutions just like the other committees and 
would be bound by rules of procedure and imple-
mentation that respect the mutual sovereignty of 
all parties. 
Nongovernmental organizations such as World 
Vision, as well as some WHO member states, have 
introduced this concept together with other pro-
posals for better global governance into the infor-
mal discussions around WHA 2010. The incom-
ing chair of the WHO Executive Board echoed this 
call in his acceptance speech. He drew attention 
to the fact that the board needs to pay more at-
tention to global-level issues which require effec-
tive global governance. He indicated that this al-
so means that other actors in health have to be-
come more accountable, and that he sees propos-
als like that for establishing a Committee C—in-
tended to channel the voice of these health actors 
as part of the WHA deliberations—as worthy of 
further consideration. It seems that there is gen-
eral agreement that the time has come for a con-
structive debate, within the WHO governing bod-
ies as well.
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